Literature DB >> 15024550

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.

Una C Campbell1, Kush Lalwani, Lisa Hernandez, Gene G Kinney, P Jeffrey Conn, Linda J Bristow.   

Abstract

RATIONALE: Recent studies have shown that metabotropic glutamate receptor 5 (mGluR5) can modulate N-methyl-D-aspartate (NMDA) receptor function in vivo. For example, the mGluR5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP) can potentiate PCP (phencyclidine)-evoked hyperactivity and PCP-induced disruptions in pre-pulse inhibition (PPI) in rats.
OBJECTIVE: To extend these previous behavioral findings and determine whether the mGluR5 antagonist MPEP can modulate the disruptions in learning and memory induced by PCP in rats.
METHODS: The effects of MPEP, alone and in combination with PCP, were evaluated in rats trained to perform a repeated acquisition procedure (learning) or a delayed non-matching to position (DNMTP) radial maze task (spatial memory).
RESULTS: In the repeated acquisition task, MPEP (0-10 mg/kg, IP) dose-dependently decreased response rates but had no effect on response accuracy. In contrast, PCP (0.625-1.25 mg/kg, SC) reduced response rate and response accuracy in a dose-dependent manner. Although MPEP (10 mg/kg, IP) had no effect when administered alone, the mGluR5 antagonist potentiated the disruptions in learning induced by a low dose of PCP (0.625 mg/kg, SC). In the DNMTP maze task, MPEP (0-10 mg/kg, IP) had no effect on spatial memory, whereas PCP (1.25-2.5 mg/kg, SC) produced a dose-dependent disruption. MPEP (10 mg/kg, IP) potentiated the impairments in memory induced by PCP (1.25 mg/kg, SC).
CONCLUSION: The mGluR5 antagonist, MPEP, potentiated the disruptions in learning and memory induced by PCP. These behavioral data extend previous behavioral findings and further suggest that mGluR5 can modulate NMDA receptor function in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024550     DOI: 10.1007/s00213-004-1827-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  60 in total

1.  Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

Authors:  H Awad; G W Hubert; Y Smith; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  An experimental analysis of the effects of d-amphetamine and cocaine on the acquisition and performance of response chains in monkeys.

Authors:  D M Thompson; J M Moerschbaecher
Journal:  J Exp Anal Behav       Date:  1979-11       Impact factor: 2.468

Review 3.  Direct and indirect modulation of the N-methyl D-aspartate receptor.

Authors:  M J Marino; P Jeffrey Conn
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-02

4.  SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats.

Authors:  J Brodkin; J M Moerschbaecher
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

5.  Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.

Authors:  Y M Lu; Z Jia; C Janus; J T Henderson; R Gerlai; J M Wojtowicz; J C Roder
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

6.  Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.

Authors:  C M Campbell; E R Butelman; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

7.  [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.

Authors:  Jeffery J Anderson; Sara P Rao; Blake Rowe; Darlene R Giracello; Greg Holtz; Deborah F Chapman; Lida Tehrani; Margaret J Bradbury; Nicholas D P Cosford; Mark A Varney
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

8.  Meeting report; "Molecular neurobiological mechanisms in schizophrenia: seeking a synthesis," April 11-14, 1999.

Authors:  A B Goodman; A B Pardee
Journal:  Biol Psychiatry       Date:  2000-08-01       Impact factor: 13.382

9.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Authors:  R S Keefe; S G Silva; D O Perkins; J A Lieberman
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

10.  Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats.

Authors:  A Pilc; A Kłodzińska; P Brański; G Nowak; A Pałucha; B Szewczyk; E Tatarczyńska; E Chojnacka-Wójcik; J M Wierońska
Journal:  Neuropharmacology       Date:  2002-08       Impact factor: 5.250

View more
  50 in total

1.  Interaction of blockers of ionotropic NMDA receptors and metabotropic glutamate receptors in a working memory test in rats.

Authors:  Y A Novitskaya; O A Dravolina; E E Zvartau; W Danysz; A Y Bespalov
Journal:  Neurosci Behav Physiol       Date:  2010-07-17

Review 2.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

Review 3.  Targeting glutamate synapses in schizophrenia.

Authors:  Julie R Field; Adam G Walker; P Jeffrey Conn
Journal:  Trends Mol Med       Date:  2011-09-28       Impact factor: 11.951

Review 4.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

5.  Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease.

Authors:  Nathalie Turle-Lorenzo; Nathalie Breysse; Christelle Baunez; Marianne Amalric
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

Review 6.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

7.  Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5.

Authors:  Emma L Burrows; Caitlin E McOmish; Laetitia S Buret; Maarten Van den Buuse; Anthony J Hannan
Journal:  Neuropsychopharmacology       Date:  2015-02-10       Impact factor: 7.853

8.  Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats.

Authors:  S W Fowler; A K Ramsey; J M Walker; P Serfozo; M F Olive; T R Schachtman; A Simonyi
Journal:  Neurobiol Learn Mem       Date:  2010-11-17       Impact factor: 2.877

Review 9.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

10.  The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats.

Authors:  Jason P Schroeder; David H Overstreet; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.